Bromopride

CAS No. 4093-35-0

Bromopride( Bromopride | VAL 13081 | VA- 13081 | VAL13081 )

Catalog No. M14407 CAS No. 4093-35-0

Bromopride is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 65 In Stock
10MG 113 In Stock
25MG 255 In Stock
50MG 377 In Stock
100MG 537 In Stock
200MG 749 In Stock
500MG 1143 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bromopride
  • Note
    Research use only, not for human use.
  • Brief Description
    Bromopride is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic.
  • Description
    Bromopride is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic. It is not available in the United States or the United Kingdom.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bromopride | VAL 13081 | VA- 13081 | VAL13081
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    4093-35-0
  • Formula Weight
    344.25
  • Molecular Formula
    C14H22BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    COC1=CC(N)=C(Br)C=C1C(NCCN(CC)CC)=O
  • Chemical Name
    4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-o-anisamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tonini M, et al. Aliment Pharmacol Ther. 2004 Feb 15;19(4):379-90.
molnova catalog
related products
  • A-68930 hydrochlorid...

    A-68930 is a potent, specific, orally bioavailable agonist of the D1 Dopamine receptor with EC50 of 2.5 nM.

  • Syrosingopine

    Syrosingopine has selective depleting effect on brain amines is potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor.

  • Pramipexole dihydroc...

    A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.